USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma

Diagnostic Pathology

Table 2 ESCC patient characteristics and USP9X expression

Characteristic	Total (n = 102)	No. of USP9X positive expression cases (%)	P value
Age (years)			0.961
≤59	60	24 (40.0)
≥60	42	17 (40.5)
Gender			0.928
Male	85	34 (40.0)
Female	17	7 (41.2)
Location			0.763
Upper	6	2 (33.3)
Middle	75	29 (38.7)
Lower	21	10 (47.6)
Tumor length			0.717
≤5 cm	60	25 (41.7)
>5 cm	42	16 (38.1)
Histological grades			0.123
G1^a	22	13 (59.1)
G2^a	58	20 (34.5)
G3^a	22	8 (36.4)
Depth of invasion			0.046
T1-T2	57	18 (31.6)
T3-T4	45	23 (51.1)
Lymph node metastasis			0.032
Positive	49	25 (51.0)
Negative	53	16 (30.2)
TNM stage			0.112
I-II	57	19 (33.3)
III-IV	45	22 (48.9)

^aG3, well-differentiated carcinoma; G2, moderately-differentiated carcinoma; G1, poorly-differentiated carcinoma.

ISSN: 1746-1596